Ever wondered why your trip to the mechanic starts with a charge before they even touch your car? That’s the diagnostic fee ...
A new blood test that could help doctors identify whether a patient has Alzheimer’s disease was cleared by the FDA last week.
The "access flywheel" is four tightly linked moves any corporate-clinic partnership can use to expand early-detection ...
The test is intended for adults 55 and older in the United States who are showing signs or symptoms of cognitive decline.
19don MSN
Simple blood test gets green light by FDA to improve early detection of Alzheimer’s disease
Simple blood test gets green light by FDA to improve early detection of Alzheimer’s disease - Millions of Americans are living with Alzheimer’s and hundreds of thousands are diagnosed each year ...
A new study may finally change how amyotrophic lateral sclerosis (ALS) is diagnosed. Scientists from UCLA Health and the ...
The Galleri blood test by Grail can be given annually and looks for the DNA ‘fingerprint’ of more than 50 deadly cancers.
Pharmaceutical Technology on MSN
FDA greenlight for Roche’s Alzheimer’s disease test sparks care paradigm shift
The US Food and Drug Administration’s (FDA) recent clearance of Roche’s blood-based Alzheimer’s disease test will boost ...
Tired without answers? Years‑long limbo may be nearing its end as scientists spotlight measurable clues behind relentless ...
An important scientific study published in The Lancet shows the strong public health impact of deploying molecular diagnostics closer to the people.
AI algorithm has achieved remarkable accuracy in detecting cardiac amyloidosis, outperforming traditional diagnostic methods.
Scientists at UCSF have uncovered evidence that multiple sclerosis silently damages the brain years before diagnosis. By ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results